These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28741672)

  • 1. Finding of increased caudate nucleus in patients with Alzheimer's disease.
    Persson K; Bohbot VD; Bogdanovic N; Selbaek G; Braekhus A; Engedal K
    Acta Neurol Scand; 2018 Feb; 137(2):224-232. PubMed ID: 28741672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
    Almeida OP; Burton EJ; McKeith I; Gholkar A; Burn D; O'Brien JT
    Dement Geriatr Cogn Disord; 2003; 16(2):57-63. PubMed ID: 12784028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmentation and volumetric analysis of the caudate nucleus in Alzheimer's disease.
    Jiji S; Smitha KA; Gupta AK; Pillai VP; Jayasree RS
    Eur J Radiol; 2013 Sep; 82(9):1525-30. PubMed ID: 23664648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully automated structural MRI of the brain in clinical dementia workup.
    Persson K; Selbæk G; Brækhus A; Beyer M; Barca M; Engedal K
    Acta Radiol; 2017 Jun; 58(6):740-747. PubMed ID: 27687251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
    Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
    Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episodic memory in depression: the unique contribution of the anterior caudate and hippocampus.
    Jayaweera HK; Hickie IB; Duffy SL; Mowszowski L; Norrie L; Lagopoulos J; Naismith SL
    Psychol Med; 2016 Jul; 46(10):2189-99. PubMed ID: 27150660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects.
    Madsen SK; Ho AJ; Hua X; Saharan PS; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neurobiol Aging; 2010 Aug; 31(8):1312-25. PubMed ID: 20538376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's Disease.
    Cavedo E; Suppa P; Lange C; Opfer R; Lista S; Galluzzi S; Schwarz AJ; Spies L; Buchert R; Hampel H; ;
    J Alzheimers Dis; 2017; 60(1):151-164. PubMed ID: 28777748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease.
    Möller C; Dieleman N; van der Flier WM; Versteeg A; Pijnenburg Y; Scheltens P; Barkhof F; Vrenken H
    J Alzheimers Dis; 2015; 44(2):635-47. PubMed ID: 25322925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
    Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease.
    Teipel SJ; Ewers M; Wolf S; Jessen F; Kölsch H; Arlt S; Luckhaus C; Schönknecht P; Schmidtke K; Heuser I; Frölich L; Ende G; Pantel J; Wiltfang J; Rakebrandt F; Peters O; Born C; Kornhuber J; Hampel H
    Psychiatry Res; 2010 Jun; 182(3):244-50. PubMed ID: 20493672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
    Teipel S; Grothe MJ;
    J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcortical nuclei in Alzheimer's disease: a volumetric and diffusion kurtosis imaging study.
    Wang ML; Wei XE; Fu JL; Li W; Yu MM; Li PY; Li WB
    Acta Radiol; 2018 Nov; 59(11):1365-1371. PubMed ID: 29482345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Liu Y; Paajanen T; Zhang Y; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    Neurobiol Aging; 2010 Aug; 31(8):1375-85. PubMed ID: 20447732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.